FindTrial
Sign In

Collection of technical treatment parameters during selective retina therapy (SRT) using R:GEN in patients with diabetic retinopathy (DME) and chorioretinopathy centralis serosa - Retrospective safety and efficacy analysis

Collection of technical treatment parameters during selective retina therapy (SRT) using R:GEN in patients with diabetic retinopathy (DME) and chorioretinopathy centralis serosa - Retrospective safety and efficacy analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031038
Enrollment
100
Registered
2023-01-16
Start date
2017-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H35.7

Interventions

Group 1: The data of the patients examined in the study of the survey of technical treatment parameters serve as a basis for the retrospective analysis on the safety and effect

Sponsors

Medizinische Hochschule hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: Lack of capacity to consent

Design outcomes

Primary

MeasureTime frame
The aim of the study is to retrospectively evaluate the safety and efficacy of Selective Retinal Therapy (SRT) laser therapy.—

Secondary

MeasureTime frame
retinal atrophy Visus central retinal thickness—

Countries

Germany

Contacts

Public ContactJan Tode

Medizinische Hochschule hannover

tode.jan@mh-hannover.de+49 511 532 3061

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026